The AO Foundation, a global leader in musculoskeletal disorder treatment research, has selected TransPerfect Life Sciences' Trial Interactive platform to digitize and modernize its clinical trial operations. This strategic partnership, announced on May 13, 2025, will support the foundation's upcoming clinical trials with advanced eClinical solutions including eISF, Study Collaborate, and eTMF.
Based in Davos, Switzerland, the AO Foundation is transitioning from legacy systems and paper-based processes to a fully digital and inspection-ready infrastructure. This significant technological upgrade aims to enhance the foundation's research capabilities in musculoskeletal disorders and trauma treatment.
"Our collaboration with the AO Foundation reflects a shared commitment to advancing healthcare through innovation," commented Michael Smyth, Division President of Trial Interactive. "By transitioning from legacy systems and paper-based processes to our robust and interoperable eClinical platform, the AO Foundation is well-positioned to achieve operational excellence and regulatory compliance."
Dr. Katrin Simioni, Deputy Head of Clinical Operations at the AO Foundation, emphasized the alignment between the organizations: "Trial Interactive's expertise is an excellent match to our engagement in clinical trials. Their platforms offer all features we need to improve our workflows, ensuring high-quality studies for our mission to improve patient treatment."
Digital Transformation in Clinical Research
The implementation of Trial Interactive's platform represents a significant advancement in how the AO Foundation will manage its clinical trials. The 21 CFR part 11-compliant, AI-powered platform provides an author-to-archive collaboration experience with comprehensive solutions for clinical document management, site selection, site activation, e-learning, compliance training, quality management, and clinical trial management systems (CTMS).
These digital tools will enable the foundation's project managers and data scientists to streamline operations, reduce compliance risks, expedite timelines, and ultimately improve operational excellence. The platform's interoperability and seamless indexing to the electronic Trial Master File (eTMF) further enhance its utility for complex clinical research.
AO Foundation's Global Impact
The AO Foundation has established itself as a preeminent organization in the field of musculoskeletal research and education since its founding by Swiss surgeons in 1958. The foundation has developed specialty areas for trauma, spine, craniomaxillofacial (CMF), veterinary (VET), and reconstructive surgery (Recon).
Today, the AO Foundation maintains one of the most extensive global networks in healthcare, connecting over half a million professionals. Its educational reach is equally impressive, offering more than 850 educational events annually worldwide, supported by approximately 8,000 faculty members and attended by over 70,000 participants. To date, the foundation has trained more than one million course participants and counts over 20,000 surgeon members working across its specialty fields.
The foundation's approach to innovation spans the entire spectrum from bench to bedside, encompassing basic research, product development, clinical validation, and valorization. Its world-leading institutes in research and innovation deliver value-added products and services to clinical specialties, surgeons, operating room personnel, and partners globally.
TransPerfect's Expanding Role in Life Sciences
TransPerfect Life Sciences, the parent company of Trial Interactive, continues to strengthen its position as a leading provider of content solutions and technologies supporting global clinical trials and product development for the biopharmaceutical industry.
With offices in over 140 cities worldwide, TransPerfect offers comprehensive solutions including clinical trial management technology and services, pharmacovigilance and safety solutions, translation and language services, and call center support. The company positions itself as a partner that simplifies the path from lab to launch by driving quality, mitigating compliance risk, and enhancing patient engagement.
This partnership between the AO Foundation and Trial Interactive represents a convergence of medical expertise and technological innovation, potentially accelerating advances in the treatment of musculoskeletal disorders and trauma through more efficient and compliant clinical research processes.
